While CXCL2, IL8 and their respective receptor CXCR2 seem to contribute to angiogenesis and tumorigenesis in GBM [13,18], there is also evidence suggesting an important role of those molecules in circumvention of anti-angiogenic therapy in gliomas. This evidence concerns the gene CXCL8 and glioma.